Pdt Partners, LLC Guardant Health, Inc. Transaction History

Pdt Partners, LLC

$981 Million
Q2 2024

A detailed history of Pdt Partners, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 144,585 shares of GH stock, worth $3.31 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

144,585

Previous 68,666 110.56%

Holding current value

$3.31 Million

Previous $1.42 Million 194.84%

% of portfolio

0.43%

Previous 0.14%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$16.07 - $31.84 $1.22 Million - $2.42 Million	75,919 Added 110.56%	144,585 $4.18 Million
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $366,873 - $576,331	-21,417 Reduced 23.77%	68,666 $1.42 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $1.18 Million - $1.61 Million	-54,546 Reduced 37.71%	90,083 $2.44 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $404,698 - $626,969	-15,686 Reduced 9.78%	144,629 $4.29 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $365,047 - $662,628	17,433 Added 12.2%	160,315 $5.74 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $1.3 Million - $1.91 Million	56,723 Added 65.84%	142,882 $3.35 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $2.19 Million - $5.15 Million	86,159 New	86,159 $2.34 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $1.09 Million - $1.45 Million	-11,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $2.33 Million - $3.52 Million	-21,216 Reduced 65.86%	11,000 $1.37 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $4.83 Million - $6.81 Million	-37,996 Reduced 54.12%	32,216 $4.92 Million
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $1.2 Million - $1.63 Million	-12,017 Reduced 14.61%	70,212 $9.05 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $1.24 Million - $1.73 Million	-15,471 Reduced 15.84%	82,229 $9.19 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $5.91 Million - $9.53 Million	97,700 New	97,700 $7.93 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $2.74 Million - $4.12 Million	-46,377 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $1.23 Million - $1.7 Million	-20,595 Reduced 30.75%	46,377 $3.62 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $4.19 Million - $7.39 Million	66,972 New	66,972 $4.28 Million

Others Institutions Holding GH

# of Institutions

331

Shares Held

116M

Call Options Held

680K

Put Options Held

1.66M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account